Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-061577
Filing Date
2019-12-20
Accepted
2019-12-20 16:39:41
Documents
2
Period of Report
2019-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1593
2 POA DOCUMENT poa.txt EX-24.3_884525 4020
  Complete submission text file 0001209191-19-061577.txt   7021
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 6770 Blank Checks

Mailing Address 320 W 37TH STREET, 3RD FLOOR NEW YORK NY 10016
Business Address
Yanchik Connealy Pamela (Reporting) CIK: 0001796310 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 191302081